Evidence map›Paper›PMID 38037039›Full record

ArticleCell communication and signaling : CCS2023

CP-25 inhibits the hyperactivation of rheumatic synoviocytes by suppressing the switch in G

Mingli Ge, Li Wu, Feng He, Yu Tai, Ruhong Fang, Dafei Han, Paipai Guo, Hao Liu, Yong Hu, Shenglin Xu and 2 more

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Cell communication and signaling : CCS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Mingli Ge *Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China.
Li Wu *Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China.
Feng He *Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China.
Yu TaiInstitute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China.
Ruhong FangInstitute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China.
Dafei HanInstitute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China.
Paipai GuoInstitute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China.
Hao LiuSchool of Pharmacy, Bengbu Medical College, Bengbu, 233030, China.
Yong HuDepartment of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Shenglin XuDepartment of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China. xushenglin@ahmu.edu.cn.
Wei WeiInstitute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China. wwei@ahmu.edu.cn.
Qingtong WangInstitute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China. hfwqt727@163.com.
Anhui Medical University · CNMinistry of Education of the People's Republic of China · CNBengbu Medical College · CNFirst Affiliated Hospital of Anhui Medical University · CN

Funding

Academic Funding for Top-notch Talents in University Disciplines (Majors) of Anhui Province gxbjZD2021047Anhui Provincial Key R&D Programs 2022e07020042Collaborative Innovation Project of Key Scientific Research Platform in Anhui Universities GXXT-2020-066Program for Upgrading Scientific Research Level of Anhui Medical University 2019xkjT008the Anhui Provincial Natural Science Foundation for Distinguished Young Scholars 1808085J28the National Natural Science Foundation of China 81973332the Program for Upgrading Basic and Clinical Collaborative Research of Anhui Medical University 2020xkjT033
6 · The paper itself

Abstract

In essence, the β

Indexed as

Arthritis, ExperimentalSynoviocytesAnimalsCell ProliferationCells, CulturedEpinephrineFibroblastsGlucosidesInflammationIsoproterenolMonoterpenesRatsSignal TransductionEpinephrineGlucosidesIsoproterenolMonoterpenespaeoniflorin-6'-O-benzenesulfonateFibroblast-like synoviocytesGαs-Gαi coupling switchPaeoniflorin-6′-O-benzene sulfonateRheumatoid arthritisβ2 adrenergic receptor

Identifiers

PMID38037039
PMCPMC10688045
OpenAlexW4389199401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.